So while semaglutide itself may not directly cause vein problems, the weight loss it triggers could contribute to changes in vein appearance
Cardiovascular benefits: Ozempic has been shown to reduce the risk of cardiovascular events in some people with type 2 diabetes and established heart disease
The trial involved 443 participants who had inadequate glycemic control despite being on stable doses of oral antihyperglycemic medications
The comparison between phentermine and GLP-1 medications and the phentermine versus semaglutide comparison may also be relevant for patients exploring lower-cost pharmaceutical alternatives when GLP-1 access becomes restricted
Each Ozempic lawsuit is evaluated on an individual basis, with our legal team examining the specific circumstances and health outcomes of each client
Any references to product characteristics, including but not limited to stability, preservation, or composition, are provided solely for general informational purposes within a research context and do not imply suitability for any other use